Trials / Terminated
TerminatedNCT05915897
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Sanguine Biosciences · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Chronic Granulomatous Disease (CGD). The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Specimen Donation | blood donation |
Timeline
- Start date
- 2023-05-23
- Primary completion
- 2024-03-25
- Completion
- 2024-03-25
- First posted
- 2023-06-23
- Last updated
- 2024-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05915897. Inclusion in this directory is not an endorsement.